For help on how to get the results you want, see our search tips.
1206 results
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Aflunov
influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/turkey/Turkey/1/05 (H5N1)-like strain (NIBRG-23), Influenza, Human, Immunization, Disease Outbreaks
Date of authorisation: 28/11/2010, Revision: 12, Authorised, Last updated: 11/11/2019 -
List item
Human medicine European public assessment report (EPAR): Afstyla
lonoctocog alfa, Hemophilia A
Date of authorisation: 04/01/2017,
, Revision: 7, Authorised, Last updated: 26/08/2020
-
List item
Human medicine European public assessment report (EPAR): Aimovig
erenumab, Migraine Disorders
Date of authorisation: 26/07/2018,, Revision: 5, Authorised, Last updated: 09/09/2020
-
List item
Human medicine European public assessment report (EPAR): Ajovy
fremanezumab, Migraine Disorders
Date of authorisation: 28/03/2019,, Revision: 4, Authorised, Last updated: 04/11/2020
-
List item
Human medicine European public assessment report (EPAR): Akynzeo
netupitant, palonosetron hydrochloride, Vomiting, Cancer, Nausea
Date of authorisation: 27/05/2015, Revision: 8, Authorised, Last updated: 29/06/2020 -
List item
Human medicine European public assessment report (EPAR): Aldara
imiquimod, Condylomata Acuminata, Keratosis, Keratosis, Actinic, Carcinoma, Basal Cell
Date of authorisation: 18/09/1998, Revision: 27, Authorised, Last updated: 15/12/2020 -
List item
Human medicine European public assessment report (EPAR): Aldurazyme
laronidase, Mucopolysaccharidosis I
Date of authorisation: 09/06/2003, Revision: 20, Authorised, Last updated: 09/12/2020 -
List item
Human medicine European public assessment report (EPAR): Alecensa
alectinib hydrochloride, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 16/02/2017,, Revision: 8, Authorised, Last updated: 19/06/2020
-
List item
Human medicine European public assessment report (EPAR): Alimta
pemetrexed, Mesothelioma, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 20/09/2004, Revision: 25, Authorised, Last updated: 27/10/2020 -
List item
Human medicine European public assessment report (EPAR): Alkindi
hydrocortisone, Adrenal Insufficiency
Date of authorisation: 09/02/2018, Revision: 5, Authorised, Last updated: 18/11/2019 -
List item
Human medicine European public assessment report (EPAR): Alli (previously Orlistat GSK)
orlistat, Obesity
Date of authorisation: 22/07/2007, Revision: 17, Authorised, Last updated: 24/08/2020 -
List item
Human medicine European public assessment report (EPAR): Alofisel
darvadstrocel, Rectal Fistula
Date of authorisation: 23/03/2018,, 
, Revision: 6, Authorised, Last updated: 04/01/2021
-
List item
Human medicine European public assessment report (EPAR): Aloxi
palonosetron hydrochloride, Vomiting, Cancer
Date of authorisation: 22/03/2005, Revision: 21, Authorised, Last updated: 19/07/2018 -
List item
Human medicine European public assessment report (EPAR): Alprolix
eftrenonacog alfa, Hemophilia B
Date of authorisation: 12/05/2016,, , Revision: 5, Authorised, Last updated: 04/11/2020
-
List item
Human medicine European public assessment report (EPAR): Alunbrig
brigatinib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 22/11/2018,, Revision: 5, Authorised, Last updated: 27/01/2021
-
List item
Human medicine European public assessment report (EPAR): Ambirix
hepatitis A virus (inactivated), hepatitis B surface antigen, Hepatitis B, Hepatitis A, Immunization
Date of authorisation: 30/08/2002, Revision: 15, Authorised, Last updated: 24/04/2020 -
List item
Human medicine European public assessment report (EPAR): Ambrisentan Mylan
ambrisentan, Hypertension, Pulmonary
Date of authorisation: 20/06/2019,
, Revision: 1, Authorised, Last updated: 20/03/2020
-
List item
Human medicine European public assessment report (EPAR): Ameluz
5-aminolevulinic acid hydrochloride, Keratosis, Actinic, Carcinoma, Basal Cell
Date of authorisation: 13/12/2011, Revision: 16, Authorised, Last updated: 18/12/2020 -
List item
Human medicine European public assessment report (EPAR): Amgevita
adalimumab, Arthritis, Psoriatic, Colitis, Ulcerative, Arthritis, Juvenile Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Crohn Disease, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017,, 
, Revision: 8, Authorised, Last updated: 12/03/2020
-
List item
Human medicine European public assessment report (EPAR): Amglidia
glibenclamide, Diabetes Mellitus
Date of authorisation: 24/05/2018,, Revision: 3, Authorised, Last updated: 08/10/2019
-
List item
Human medicine European public assessment report (EPAR): Amlodipine / Valsartan Mylan
Amlodipine besilate, valsartan, Hypertension
Date of authorisation: 22/03/2016,, Revision: 6, Authorised, Last updated: 02/02/2021
-
List item
Human medicine European public assessment report (EPAR): Ammonaps
Sodium phenylbutyrate, Ornithine Carbamoyltransferase Deficiency Disease, Citrullinemia, Carbamoyl-Phosphate Synthase I Deficiency Disease
Date of authorisation: 07/12/1999, Revision: 20, Authorised, Last updated: 11/11/2020 -
List item
Human medicine European public assessment report (EPAR): Amsparity
adalimumab, Arthritis, Rheumatoid, Arthritis, Juvenile Rheumatoid, Psoriasis, Arthritis, Psoriatic, Spondylitis, Ankylosing, Uveitis, Colitis, Ulcerative, Crohn Disease, Hidradenitis Suppurativa
Date of authorisation: 13/02/2020,, , Revision: 1, Authorised, Last updated: 01/12/2020
-
List item
Human medicine European public assessment report (EPAR): Amyvid
florbetapir (18F), Radionuclide Imaging
Date of authorisation: 14/01/2013, Revision: 13, Authorised, Last updated: 12/01/2021 -
List item
Human medicine European public assessment report (EPAR): Anagrelide Mylan
Anagrelide hydrochloride, Thrombocythemia, Essential
Date of authorisation: 15/02/2018,, Revision: 2, Authorised, Last updated: 08/06/2020